Express Pharma

facebook
twitter
google_plus
Email

Browsing tag

SCD-044

Sun Pharma starts Phase II trial of SCD-044 for moderate to severe plaque psoriasis

SPARC and Sun Pharma enter into license agreement for SCD-044

Home
- Drug approvals
- Deals
- Policies
- Technology
- Leadership
- Research
- Logistics
- Infrastructure
- Marketing
- HR
- Biotech
- More
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
- Upcoming Events
Videos

View Desktop Version